Copyright Reports & Markets. All rights reserved.

Global Endometrial Cancer Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Endometrial Cancer Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Endometrial Cancer Treatment Market Size Growth Rate by Product
      • 1.4.2 Chemotherapy
      • 1.4.3 Surgical
    • 1.5 Market by End User
      • 1.5.1 Global Endometrial Cancer Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Endometrial Cancer Treatment Market Size
      • 2.1.1 Global Endometrial Cancer Treatment Revenue 2014-2025
      • 2.1.2 Global Endometrial Cancer Treatment Sales 2014-2025
    • 2.2 Endometrial Cancer Treatment Growth Rate by Regions
      • 2.2.1 Global Endometrial Cancer Treatment Sales by Regions
      • 2.2.2 Global Endometrial Cancer Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Endometrial Cancer Treatment Sales by Manufacturers
      • 3.1.1 Endometrial Cancer Treatment Sales by Manufacturers
      • 3.1.2 Endometrial Cancer Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Endometrial Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Endometrial Cancer Treatment Revenue by Manufacturers
      • 3.2.1 Endometrial Cancer Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Endometrial Cancer Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Endometrial Cancer Treatment Price by Manufacturers
    • 3.4 Endometrial Cancer Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Endometrial Cancer Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Endometrial Cancer Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Endometrial Cancer Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Endometrial Cancer Treatment Sales by Product
    • 4.2 Global Endometrial Cancer Treatment Revenue by Product
    • 4.3 Endometrial Cancer Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Endometrial Cancer Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Endometrial Cancer Treatment by Countries
      • 6.1.1 North America Endometrial Cancer Treatment Sales by Countries
      • 6.1.2 North America Endometrial Cancer Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Endometrial Cancer Treatment by Product
    • 6.3 North America Endometrial Cancer Treatment by End User

    7 Europe

    • 7.1 Europe Endometrial Cancer Treatment by Countries
      • 7.1.1 Europe Endometrial Cancer Treatment Sales by Countries
      • 7.1.2 Europe Endometrial Cancer Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Endometrial Cancer Treatment by Product
    • 7.3 Europe Endometrial Cancer Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Endometrial Cancer Treatment by Countries
      • 8.1.1 Asia Pacific Endometrial Cancer Treatment Sales by Countries
      • 8.1.2 Asia Pacific Endometrial Cancer Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Endometrial Cancer Treatment by Product
    • 8.3 Asia Pacific Endometrial Cancer Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Endometrial Cancer Treatment by Countries
      • 9.1.1 Central & South America Endometrial Cancer Treatment Sales by Countries
      • 9.1.2 Central & South America Endometrial Cancer Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Endometrial Cancer Treatment by Product
    • 9.3 Central & South America Endometrial Cancer Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Endometrial Cancer Treatment by Countries
      • 10.1.1 Middle East and Africa Endometrial Cancer Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Endometrial Cancer Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Endometrial Cancer Treatment by Product
    • 10.3 Middle East and Africa Endometrial Cancer Treatment by End User

    11 Company Profiles

    • 11.1 Ariad
      • 11.1.1 Ariad Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Ariad Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Ariad Endometrial Cancer Treatment Products Offered
      • 11.1.5 Ariad Recent Development
    • 11.2 Abbott
      • 11.2.1 Abbott Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott Endometrial Cancer Treatment Products Offered
      • 11.2.5 Abbott Recent Development
    • 11.3 BD
      • 11.3.1 BD Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BD Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BD Endometrial Cancer Treatment Products Offered
      • 11.3.5 BD Recent Development
    • 11.4 GlaxoSmithKline
      • 11.4.1 GlaxoSmithKline Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 GlaxoSmithKline Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 GlaxoSmithKline Endometrial Cancer Treatment Products Offered
      • 11.4.5 GlaxoSmithKline Recent Development
    • 11.5 Merck
      • 11.5.1 Merck Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Merck Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Merck Endometrial Cancer Treatment Products Offered
      • 11.5.5 Merck Recent Development
    • 11.6 Novartis
      • 11.6.1 Novartis Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Novartis Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Novartis Endometrial Cancer Treatment Products Offered
      • 11.6.5 Novartis Recent Development
    • 11.7 Sanofi
      • 11.7.1 Sanofi Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Sanofi Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Sanofi Endometrial Cancer Treatment Products Offered
      • 11.7.5 Sanofi Recent Development
    • 11.8 Siemens
      • 11.8.1 Siemens Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Siemens Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Siemens Endometrial Cancer Treatment Products Offered
      • 11.8.5 Siemens Recent Development
    • 11.9 Roche
      • 11.9.1 Roche Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Roche Endometrial Cancer Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Roche Endometrial Cancer Treatment Products Offered
      • 11.9.5 Roche Recent Development

    12 Future Forecast

    • 12.1 Endometrial Cancer Treatment Market Forecast by Regions
      • 12.1.1 Global Endometrial Cancer Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Endometrial Cancer Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Endometrial Cancer Treatment Market Forecast by Product
      • 12.2.1 Global Endometrial Cancer Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Endometrial Cancer Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Endometrial Cancer Treatment Market Forecast by End User
    • 12.4 North America Endometrial Cancer Treatment Forecast
    • 12.5 Europe Endometrial Cancer Treatment Forecast
    • 12.6 Asia Pacific Endometrial Cancer Treatment Forecast
    • 12.7 Central & South America Endometrial Cancer Treatment Forecast
    • 12.8 Middle East and Africa Endometrial Cancer Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Endometrial Cancer Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Endometrial Cancer Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Endometrial Cancer Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Endometrial Cancer Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Endometrial Cancer Treatment in these regions.
      This research report categorizes the global Endometrial Cancer Treatment market by top players/brands, region, type and end user. This report also studies the global Endometrial Cancer Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Ariad
      Abbott
      BD
      GlaxoSmithKline
      Merck
      Novartis
      Sanofi
      Siemens
      Roche

      Market size by Product
      Chemotherapy
      Surgical
      Market size by End User
      Hospital
      Clinic

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Endometrial Cancer Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Endometrial Cancer Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Endometrial Cancer Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Endometrial Cancer Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Endometrial Cancer Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Endometrial Cancer Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now